Skip to main content


Nuclear Medicine and Molecular Imaging

Nuclear Medicine and Molecular Imaging OnlineFirst articles

05.02.2018 | Original Article

Analysis of Iodine Content in Salts and Korean Sauces for Low-Iodine Diet Education in Korean Patients with Thyroid Cancer Preparing for Radioiodine Therapy

Patients with thyroid cancer should keep to a low-iodine diet for 1 or 2 weeks before radioiodine therapy. The purpose of the low-iodine diet is to decrease ingestion of nonradioactive iodine that is absorbed in competition with radioiodine. The …

01.02.2018 | Review

Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies

Radiomics utilizes high-dimensional imaging data to discover the association with diagnostic, prognostic, predictive endpoint or radiogenomics. It is an emerging field of study that potentially depicts the intratumoral heterogeneity from …

01.02.2018 | Interesting Image

Incidental Detection of Peri-Renal Hemorrhage on F-18 FDG PET/CT Imaging in a Patient with Polycystic Kidney Disease

A 72-year-old male patient with a history of polycystic kidney disease and lung malignancy underwent F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the evaluation of tumor recurrence. The FDG PET/CT and …

12.01.2018 | Review

Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals

Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, and spinal cord compression, decreasing quality of life by restricting …

08.01.2018 | Original Article

A Single Intraperitoneal Injection of Endotoxin Changes Glial Cells in Rats as Revealed by Positron Emission Tomography Using [11C]PK11195

Major depressive disorder (MDD) is a mood disorder characterized by a persistent feeling of sadness or a lack of interest in external stimuli. Besides the well-established role of monoaminergic system dysfunction in the pathophysiology of the …

Aktuelle Ausgaben

Über diese Zeitschrift

Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) publishes papers on nuclear medicine and a wide range of related sciences including radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal also presents original works relating to molecular imaging research, such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Content includes original articles, reviews, case reports, editorials, interesting images, and letters to the editor. Nucl Med Mol Imaging is an official journal of the Korean Society of Nuclear Medicine. KSNM members read this journal plus the official journals of the EANM and the Japanese Nuclear Medicine Society online for free.

Ethical Standards

Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirementsAll contributions should also follow the good publication practice guidelines for medical journals, which were established by Korean Association of Medical Journal Editors (

Conflict of Interest

When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist. Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The Journal may publish such disclosures if judged to be important to readers.

Weitere Informationen